Hybrid lipid-coated silver nanoparticles as programmable antimicrobial platforms: balancing silver accessibility, efficacy, and toxicity

Silver nanoparticles (AgNPs) can deliver reactive silver, but the processes that drive antimicrobial activity can also injure host cells. Lipid interfaces may modify this balance by regulating nanoparticle transformation and interactions with biological targets. This Special Report examines sodium oleate-phosphatidylcholine-alkanethiol hybrid lipid membranes (HLMs) as a case study of interfacial control, with selected alternative coatings providing comparative context. Silver accessibility is defined as a time-, environment-, and target-dependent property that requires separate measurements of silver species, nanoparticle interactions, and coating evolution. Existing HLM studies demonstrate physicochemical control and changes in developmental vertebrate or environmental toxicity under defined conditions; these findings do not establish improved antimicrobial therapeutic benefit. Representative antimicrobial and mammalian-cell studies using other coatings illustrate both the value and limitations of efficacy-toxicity comparisons. Progress requires paired biological measurements, direct assessment of coating and corona evolution, and independent validation in relevant formulations. Dental, wound, device, and intracellular uses are considered as distinct evidence needs rather than established HLM therapies.